PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Fractal Therapeutics, Cambridge, MA, USA.\', \'Department of Systems Biology, Harvard Medical School, Boston, MA, USA.\', \'Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.\', \'Stem Cell Program, Boston Children\'s Hospital, Boston, MA, USA.\', \'Department of Biomedical Engineering, University of Texas, Austin, TX, USA.\', \'Department of Economics, Assumption College, Worcester, MA, USA.\', \'International Initiative for Impact Evaluation, Cambridge, MA, USA.\', \'Georgia Institute of Technology, Atlanta, GA, USA.\', \'Halozyme Therapeutics, San Diego, CA, USA.\', \'Boston Medical Center, Boston, MA, USA.\', \'Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.\', \'Department of Medicine, Boston University School of Medicine, Boston, MA, USA.\', \'Fractal Therapeutics, Cambridge, MA, USA. arijit@fractaltx.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12889-021-10829-2
?:doi
?:hasPublicationType
?:journal
  • BMC public health
is ?:pmid of
?:pmid
?:pmid
  • 33931055
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.337
?:rankingScore_hIndex
  • 103
?:title
  • Individually optimal choices can be collectively disastrous in COVID-19 disease control.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all